Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-25-001916
Filing Date
2025-04-01
Accepted
2025-04-01 09:33:57
Documents
176
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F evax20241231_20f.htm   iXBRL 20-F 5401475
2 EXHIBIT 11.1 ex_797219.htm EX-11.1 72755
3 EXHIBIT 12.1 ex_797220.htm EX-12.1 8487
4 EXHIBIT 12.2 ex_797221.htm EX-12.2 8204
5 EXHIBIT 13.1 ex_797222.htm EX-13.1 3726
6 EXHIBIT 13.2 ex_797223.htm EX-13.2 3771
7 EXHIBIT 15.1 ex_797224.htm EX-15.1 7429
8 EXHIBIT 97.1 ex_797225.htm EX-97.1 27070
14 evaxionlogo.jpg GRAPHIC 6533
15 fig2.jpg GRAPHIC 63938
16 fig4a.jpg GRAPHIC 85113
17 fig4b.jpg GRAPHIC 79137
18 fig5.jpg GRAPHIC 44135
19 fig6.jpg GRAPHIC 24131
20 fig7.jpg GRAPHIC 35660
21 fig8.jpg GRAPHIC 45212
22 fig9.jpg GRAPHIC 43754
23 fig10.jpg GRAPHIC 91348
24 fig11.jpg GRAPHIC 89953
25 fig12.jpg GRAPHIC 22282
26 fig13.jpg GRAPHIC 28057
27 fig13b.jpg GRAPHIC 16521
28 fig14.jpg GRAPHIC 36026
29 fig15.jpg GRAPHIC 33677
30 fig16.jpg GRAPHIC 50449
31 fig17.jpg GRAPHIC 19564
32 fig18.jpg GRAPHIC 67679
33 fig19a.jpg GRAPHIC 57015
34 fig19b.jpg GRAPHIC 52801
35 fig20.jpg GRAPHIC 66207
36 logo.jpg GRAPHIC 13672
37 neoantigen.jpg GRAPHIC 59272
38 productdevelopment.jpg GRAPHIC 39604
39 stratambition.jpg GRAPHIC 37630
40 wfigure20.jpg GRAPHIC 34197
41 wfigure21.jpg GRAPHIC 24857
42 wfigure22.jpg GRAPHIC 55258
43 wfigure23.jpg GRAPHIC 54666
44 wfigure24.jpg GRAPHIC 37568
45 wfigure25.jpg GRAPHIC 34599
46 wfigure26.jpg GRAPHIC 17032
47 wfigure27.jpg GRAPHIC 39469
48 wfigure28.jpg GRAPHIC 35069
49 wfigure29.jpg GRAPHIC 75601
50 wfigure30.jpg GRAPHIC 97670
51 wfigure31.jpg GRAPHIC 57034
52 wfigure32.jpg GRAPHIC 40860
53 wfigure33.jpg GRAPHIC 18876
54 wfigure34.jpg GRAPHIC 20944
55 wfigure35.jpg GRAPHIC 18842
56 wfigure36.jpg GRAPHIC 25243
57 wfigure37.jpg GRAPHIC 29777
58 wfigure38.jpg GRAPHIC 59749
59 wfigure39.jpg GRAPHIC 26353
60 wfigure40.jpg GRAPHIC 18966
61 wfigure41.jpg GRAPHIC 26848
62 wfigure42.jpg GRAPHIC 46280
63 wfigure43.jpg GRAPHIC 55727
64 wfigure44.jpg GRAPHIC 39962
65 wfigure45.jpg GRAPHIC 18470
  Complete submission text file 0001171843-25-001916.txt   24207197

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA evax-20241231.xsd EX-101.SCH 126722
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evax-20241231_cal.xml EX-101.CAL 53308
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evax-20241231_def.xml EX-101.DEF 658762
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE evax-20241231_lab.xml EX-101.LAB 552050
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evax-20241231_pre.xml EX-101.PRE 705606
179 EXTRACTED XBRL INSTANCE DOCUMENT evax20241231_20f_htm.xml XML 3967855
Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 4552656554
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39950 | Film No.: 25797112
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)